1 |
Dafsari HS, Pemberton JG, Ferrer EA, Yammine T, Farra C, Mohammadi MH, Ghayoor Karimiani E, Hashemi N, Souaid M, Sabbagh S, Najarzadeh Torbati P, Khan S, Roze E, Moreno-De-Luca A, Bertoli-Avella AM, Houlden H, Balla T, Maroofian R. PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy. Ann Clin Transl Neurol 2022. [PMID: 35880319 DOI: 10.1002/acn3.51634] [Reference Citation Analysis]
|
2 |
Yoganathan S, Arunachal G, Gowda VK, Vinayan KP, Thomas M, Whitney R, Jain P. NTRK2-related developmental and epileptic encephalopathy: Report of 5 new cases. Seizure 2021;92:52-5. [PMID: 34425480 DOI: 10.1016/j.seizure.2021.08.008] [Reference Citation Analysis]
|
3 |
Sáenz-Farret M, Tijssen MAJ, Eliashiv D, Fisher RS, Sethi K, Fasano A. Antiseizure Drugs and Movement Disorders. CNS Drugs 2022. [PMID: 35861924 DOI: 10.1007/s40263-022-00937-x] [Reference Citation Analysis]
|
4 |
Spoto G, Saia MC, Amore G, Gitto E, Loddo G, Mainieri G, Nicotera AG, Di Rosa G. Neonatal Seizures: An Overview of Genetic Causes and Treatment Options. Brain Sci 2021;11:1295. [PMID: 34679360 DOI: 10.3390/brainsci11101295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Mastrangelo M, Galosi S, Cesario S, Renzi A, Campea L, Leuzzi V. Presenting Patterns of Genetically Determined Developmental Encephalopathies With Epilepsy and Movement Disorders: A Single Tertiary Center Retrospective Cohort Study. Front Neurol 2022;13:855134. [DOI: 10.3389/fneur.2022.855134] [Reference Citation Analysis]
|